1. Home
  2. /
  3. Press Releases & Statements

Press Releases & Statements


May 15

2019

Community Oncology Alliance Launches Major National Campaign to Stop PBM Abuses and Highlight Patient Horror Stories

PBM Abuses Campaign Launched in Conjunction with Community Oncology Hill Day, Featuring Meetings Between Members of Congress and COA Advocates The Community Oncology Alliance is launching a major national campaign to highlight the negative impact of pharmacy benefit managers (PBMs) on patients with cancer. The “PBM Abuses” campaign will ensure that PBM middlemen abuse

Read more

Apr 9

2019

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

COA Applauds the Senate Finance Committee for PBM Hearing as Part of National Efforts to Shed Light on PBM Abuses and Lower Drug Prices More Investigation and Oversight Needed to Examine Adverse Impact of PBM Abuses on Patient Care Statement from Ted Okon, Executive Director, Community Oncology Alliance (COA): Today’s Senate Finance Committee hearing

Read more

Apr 5

2019

COA Hosts Cancer Care Teams, Advocates, and Stakeholders for Largest Community Oncology Conference Ever

Pharmacy Benefit Manager (PBM) Abuses and Patient Horror Stories Take Center Stage at Annual COA Conference Physicians, Administrators, Nurses, Pharmacists, Advocates, and Stakeholders Come Together to Share Latest Innovations in Cancer Care The most successful Community Oncology Alliance (COA) Community Oncology Conference ever, wrapped up today featuring a record-breaking nearly 1,600 community oncology physicians,

Read more

Mar 26

2019

Community Oncology Alliance Names Dr. Mark E. Thompson to Newly Created Medical Director for Public Policy Position

Experienced Community Oncologist Will Provide Valuable Guidance on Public Policy Related to Patient Access to Local, Affordable Care The Community Oncology Alliance (COA) announced today that Mark E. Thompson, MD, has been appointed to the newly created staff position of Medical Director for Public Policy. For over 30 years, Dr. Thompson was a practicing community

Read more

Mar 15

2019

COA Comments: CMS CAR-T Cell Therapy Proposed Coverage Determination

COA Submits Formal Comments to CMS on Proposed CAR-T Cell Therapy Coverage Determination Today the Community Oncology Alliance (COA) submitted a formal comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding a proposed national coverage determination memo for CAR-T cell therapy. While COA is pleased that CMS is moving in the

Read more

Mar 6

2019

COA Statement on Departure of FDA Commissioner Scott Gottlieb, MD

“We are truly saddened by the departure of Scott Gottlieb, MD from the Food & Drug Administration (FDA).  The diversity of issues Commissioner Gottlieb tackled – including drug approvals, opioids, e-cigarettes/vaping, and more – and the modernization of the FDA were amazing.  During his brief tenure at the FDA, Dr. Gottlieb had to also deal

Read more

Feb 27

2019

COA Patient Advocacy Network Appoints Medical Co-Chairs

Celebrates 10 Years of Success Advocating for Community Oncology Patients, Professionals, and Practices  The Community Oncology Alliance (COA) Patient Advocacy Network (CPAN) announced the appointment of Lakshmi Aggarwal, MD of Fort Wayne Medical Oncology and Hematology as a new CPAN medical co-chair. She will join Miriam Atkins, MD of Augusta Oncology who will continue serving

Read more

Feb 1

2019

COA Applauds HHS for Taking Strong Step Towards Ending Secretive Rebate System

COA Commends Trump Administration for Plan to Lower Drug Costs for Patients The Community Oncology Alliance (COA) applauds President Donald Trump, Health and Human Services Secretary Alex Azar, Inspector General Daniel Levinson, and HHS staff for the just released, ambitious proposal to overhaul the nation’s secretive drug rebate system. This move will lower drug prices

Read more

Jan 2

2019

COA Submits Formal Comments on Medicare International Pricing Proposal

Opposes IPI as Proposed Because of Serious Concerns About Patient Impact and Legality but Working on Alternatives Releases Research Analysis on Myth of Physician Incentives in Part B System The Community Oncology Alliance (COA) recently submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) regarding the Medicare Program International Pricing Index Model

Read more

Dec 18

2018

Community Oncology Alliance Elects New Officers and Board Members

Michael Diaz, MD of Florida Cancer Specialists & Research Institute Elected President of COA Announces Formation of Standing Biosimilars Committee The Community Oncology Alliance (COA) announced today that long-time board member and volunteer Michael Diaz, MD, a practicing medical oncologist at Florida Cancer Specialists & Research Institute (FCS), has been elected president of COA. He will

Read more